Newsletters - July 1997

Boswellic acids, the biologically active ingredients of Boswellia serrata gum resin, are used to treat inflammatory disorders.

A recent report published in the European Journal of Medical Research (Jan 20, 1997) showed that treatment with Boswellia serrata gum resin induced remission of symptoms in 82% of the ulcerative colitis patients studied. This treatment compared favorably with conventional treatment using NSAIDS.

Boswellin® supplied by Sabinsa Corporation is standardized for 70% boswellic acids.

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US